General Neurology
Lavanya Visvabharathy, PhD, Anna Cervantes-Arslanian, MD, and Jonathan Rogers, PhD, provide a closer look into the phenomenon known as “long-haul COVID” and its potential neurologic effects.
General Neurology
While neurological and psychiatric sequelae of COVID-19 have been reported, more data are needed to adequately assess the effects of COVID-19 on brain health.
General Neurology
Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) is a disorder characterized by marked fatigue, exertion induced malaise, cognitive clouding (or brain fog), impaired academic/work performance, disrupted sleep, and joint/muscle pain.
General Neurology
Recent shifts in studies of sex and gender reiterate the critical need to tailor mental health care to each patient and to remain mindful about assumptions regarding sex and gender and their role in a given patient's specific challenges.
General Neurology
The clinical approach to management of Cushing disease is often complex and education on a clear approach is paramount.
General Neurology
When combined with other serotonergic agents, selective serotonin reuptake inhibitors can lead to a potentially fatal condition called serotonin syndrome, the incidence of which is likely underestimated.
General Neurology
Perhaps it is that tension between undeniable differences and inevitable merging that has led to more recent calls for cross-disciplinary cooperation.
General Neurology
The new guidelines will facilitate the design and development of clinical trials to test new therapies to minimize the burden of neurologic disability produced by neurosarcoidosis.
